NovaBridge Biosciences (NBP) EV to EBITDA (2020 - 2026)
NovaBridge Biosciences (NBP) EV to EBITDA (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EV to EBITDA |
| 1 |
Alterity Therapeutics |
767,934.24 Bn |
767,934.20 Bn |
- |
- |
| 2 |
Belite Bio |
55,234.00 Bn |
55,234.00 Bn |
- |
-873.20 |
| 3 |
Quantum Biopharma |
17,823.14 Bn |
17,823.14 Bn |
- |
-588,435.26 |
| 4 |
Legend Biotech |
3,624.50 Bn |
3,624.21 Bn |
242.10 Mn |
-199,780.23 |
| 5 |
Akari Therapeutics |
1,745.73 Bn |
1,745.73 Bn |
- |
-62,251.73 |
| 6 |
Evaxion A |
1,540.85 Bn |
1,540.84 Bn |
- |
-170,995.04 |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-304,774.20 |
| 8 |
Vertex Pharmaceuticals |
112.57 Bn |
105.33 Bn |
2.59 Bn |
22.50 |
| 9 |
Abivax |
93.46 Bn |
93.46 Bn |
- |
-315.46 |
| 10 |
NovaBridge Biosciences |
331.49 Mn |
120.65 Mn |
- |
-1.50 |
| Date | Value |
|---|
| Jun 11, 2026 |
-1.50 |
| Jun 10, 2026 |
-1.56 |
| Jun 9, 2026 |
-1.75 |
| Jun 8, 2026 |
-1.64 |
| Jun 5, 2026 |
-1.89 |
| Jun 4, 2026 |
-2.32 |
| Jun 3, 2026 |
-2.18 |
| Jun 2, 2026 |
-2.08 |
| Jun 1, 2026 |
-2.66 |
| May 29, 2026 |
-3.08 |
| May 28, 2026 |
-3.18 |
| May 27, 2026 |
-3.18 |
| May 26, 2026 |
-3.15 |
| May 22, 2026 |
-2.83 |
| May 21, 2026 |
-2.88 |
| May 20, 2026 |
-2.83 |
| May 19, 2026 |
-2.54 |
| May 18, 2026 |
-2.64 |
| May 15, 2026 |
-3.01 |
| May 14, 2026 |
-3.35 |
